TBMP

CAS No. 88-32-4

TBMP( TBMP | butylated hydroxyanisole )

Catalog No. M27137 CAS No. 88-32-4

TBMP is the viral envelope protein hemagglutinin (HA)-mediated entry novel inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG 27 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TBMP
  • Note
    Research use only, not for human use.
  • Brief Description
    TBMP is the viral envelope protein hemagglutinin (HA)-mediated entry novel inhibitor.
  • Description
    TBMP is the viral envelope protein hemagglutinin (HA)-mediated entry novel inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    TBMP | butylated hydroxyanisole
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Cleavable
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    88-32-4
  • Formula Weight
    180.247
  • Molecular Formula
    C11H16O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc1ccc(O)cc1C(C)(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337.
molnova catalog
related products
  • Phalloidin

    Phalloidin, a bicyclic heptapeptide found in Gooseberry, is involved in F-actin staining. Phalloidin is a compound that irreversibly polymerizes actin into microfilaments.

  • Alagebrium chloride

    Alagebrium Chloride?is an advanced glycation end product (AGE) inhibitor?and has proven effective in reducing systolic blood pressure and providing therapeutic benefit for patients with diastolic.

  • R 892

    Potent and selective bradykinin B1 receptor antagonist (ID50 values are 2.8 and > 600 nM at B1 and B2 receptors respectively). Exhibits no intrinsic agonist activity and is resistant to aminopeptidase and kininase II (ACE) cleavage. Displays hypertensive activity in vivo.